Form 4: OptimizeRx Director Wasson Reports Stock Transactions
SEC Form 4 Filing
Director Gregory D. Wasson reports acquisition and disposal of OptimizeRx Corp (OPRX) common stock and restricted stock units.
Summary
- On June 5, 2024, Director Gregory D. Wasson exercised 10,061 restricted stock units (RSUs) converting them into common stock.
- Also on June 5, 2024, Wasson disposed of 34,029 shares of common stock.
- On June 7, 2024, Wasson was granted 13,286 restricted stock units.
- Following these transactions, Wasson beneficially owns 47,315 shares of OptimizeRx common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence in publicly traded companies. It provides transparency to investors regarding the actions of company leadership.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a director.
Key Dates
| Date | Description |
|---|---|
| 06/07/2023 | Reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024. |
| 06/05/2024 | Restricted stock units convert into common stock on a one-for-one basis. |
| 06/05/2024 | Director Wasson exercised 10,061 restricted stock units and disposed of 34,029 shares of common stock. |
| 06/07/2024 | Director Wasson was granted 13,286 restricted stock units. |
| 06/11/2024 | Date of filing the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.